v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ (6,274) $ (8,649)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Depreciation and amortization 4,051 4,668
Provision for credit losses 19 0
Deferred income taxes (90) (3)
Shares issued for employee benefit plan 159 301
Employee and director stock-based compensation 1,784 1,904
Changes in operating assets and liabilities:    
Accounts receivable and contract assets 10,514 11,007
Inventories 2,956 4,132
Prepaid expenses and other assets (58) (3,051)
Accounts payable and accrued liabilities (5,298) (12,517)
Accrued income taxes 1,221 (567)
Net cash provided by (used for) operating activities 8,984 (2,775)
Cash flows from investing activities:    
Purchase of Blue Chip Swap securities (Note 15) (1,250) 0
Sale of Blue Chip Swap securities (Note 15) 1,088 0
Acquisitions of property, plant and equipment (1,042) (1,347)
Acquisitions of intangible assets (703) (1,019)
Net cash provided by (used for) investing activities (1,907) (2,366)
Cash flows from financing activities:    
Borrowings under lines of credit 18,000 24,000
Repayments on lines of credit (24,000) (33,000)
Treasury stock purchased (383) (1,230)
Net cash provided by (used for) financing activities (6,383) (10,230)
Effect of foreign currency exchange rates on cash and cash equivalents (88) (466)
Net increase (decrease) in cash and cash equivalents 606 (15,837)
Cash and cash equivalents at beginning of period 26,783 42,751
Cash and cash equivalents at end of period 27,389 26,914
Supplemental cash flow information:    
Income taxes paid 1,161 777
Interest paid $ 635 $ 1,368